Skip to content
  • Home
  • News
  • Corporate
    • Company Overview & History
    • Philosophy
    • CEO’s Message
    • KIYAN PHARMA Fukuroi Plant
    • About KIYAN Group
    • Electronic Public Notices
  • Business
    • 5-ALA
      • What is 5-ALA?
      • 5-ALA Manufacturing Business
    • Pharmaceutical APIs and Intermediates
    • Health Food & Cosmetics Business
    • Fertilizer, Feed & Animal Health Business
    • Drug Development & Licensing Business
  • Contact Us
    • Contact Form
    • Privacy Policy
    • FAQs (Frequently Asked Questions)
    • Careers
  • Japanese
  • Home
  • News
  • Corporate
    • Company Overview & History
    • Philosophy
    • CEO’s Message
    • KIYAN PHARMA Fukuroi Plant
    • About KIYAN Group
    • Electronic Public Notices
  • Business
    • 5-ALA
      • What is 5-ALA?
      • 5-ALA Manufacturing Business
    • Pharmaceutical APIs and Intermediates
    • Health Food & Cosmetics Business
    • Fertilizer, Feed & Animal Health Business
    • Drug Development & Licensing Business
  • Contact Us
    • Contact Form
    • Privacy Policy
    • FAQs (Frequently Asked Questions)
    • Careers
  • Japanese

2020

2020

Home » 2020
  • News

    Launch of “Mitocom Power Liquid,” a Feed for Livestock and Poultry

    December 15, 2020

  • Information

    Broadcast on NHK WORLD JAPAN’s “Catch Japan”

    November 26, 2020

  • News

    Announcement of a Specific Clinical Study Using 5-aminolevulinic Acid (5-ALA) for COVID-19 Patients by Nagasaki University

    October 29, 2020

  • News

    Partnership with Thailand’s Major Seafood Processor, Thai Union Group

    April 15, 2020

Categories

  • Information
  • News

Recent Posts

  • We have renewed the KIYAN PHARMA website! May 1, 2024
  • Intellectual Property High Court Decision on the Patent Infringement Lawsuit against Toa Industry Co., Ltd. March 28, 2024
  • Decision on Non-Acceptance of Appeal Concerning the Patent for 5-Aminolevulinic Acid Phosphate October 10, 2023
  • Report on Specific Clinical Research Using 5-Aminolevulinic Acid (5-ALA) for COVID-19 Patients September 5, 2023
  • Judgment on the Patent Infringement Lawsuit against Toa Industry Co., Ltd. July 28, 2023

KIYAN Group and Collaborating Research Institutions

KIYAN PHARMA Co., Ltd.

KIYAN PHARMA Co., Ltd.

KIYAN MEDICAL Co., Ltd.

KIYAN MEDICAL Co., Ltd.

Biozipcode, Inc.

Biozipcode, Inc.

Shiga University of Medical Science, Dep. of Regenerative Medicine

Shiga University of Medical Science, Dep. of Regenerative Medicine

KIYAN PHARMA Co., Ltd.

formerly Neopharma Japan Co., Ltd.

6-2-6 Kojimachi, Chiyoda-ku, Tokyo 102-0083, PMO Kojimachi 8th floor

Contact UsContact Us
  • Home
  • Corporate Information
  • Company Overview & History
  • Philosophy
  • CEO’s Message
  • About KIYAN Group
  • KIYAN PHARMA Fukuroi Plant
  • Electronic Public Notices
  • Business Information
  • 5-ALA
  • Pharmaceutical APIs and Intermediates
  • Health Food & Cosmetics Business
  • Fertilizer, Feed & Animal Health Business
  • Drug Development & Licensing Business
  • News
  • Contact Us
  • Privacy Policy
  • FAQs (Frequently Asked Questions)
  • Careers

© Copyright 2023 - 2025 | KIYAN PHARMA Co., Ltd. All Rights Reserved.

Page load link

KIYAN PHARMA Co., Ltd.

  • Home
  • News
  • Corporate
    • Company Overview & History
    • Philosophy
    • CEO’s Message
    • KIYAN PHARMA Fukuroi Plant
    • About KIYAN Group
    • Electronic Public Notices
  • Business
    • 5-ALA
      • What is 5-ALA?
      • 5-ALA Manufacturing Business
    • Pharmaceutical APIs and Intermediates
    • Health Food & Cosmetics Business
    • Fertilizer, Feed & Animal Health Business
    • Drug Development & Licensing Business
  • Contact Us
    • Contact Form
    • Privacy Policy
    • FAQs (Frequently Asked Questions)
    • Careers
  • Japanese
Contact Information

6-2-6 Kojimachi, Chiyoda-ku, Tokyo 102-0083, PMO Kojimachi 8th floor

Mail:info@kiyan.jp

Contact UsContact Us
Go to Top